Chromocell Therapeutics (Chromocell Therapeutics) FCF Yield % : -31.33 (As of Jun. 21, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Chromocell Therapeutics's Trailing 12-Month Free Cash Flow is $-2.80 Mil, and Market Cap is $8.94 Mil. Therefore, Chromocell Therapeutics's FCF Yield % for today is -31.33%.

The historical rank and industry rank for Chromocell Therapeutics's FCF Yield % or its related term are showing as below:

CHRO' s FCF Yield % Range Over the Past 10 Years
Min: -38.54 Med: 0 Max: 0
Current: -31.33

CHRO's FCF Yield % is ranked worse than
68.54% of 1551 companies
in the Biotechnology industry
Industry Median: -14.61 vs CHRO: -31.33

Chromocell Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Chromocell Therapeutics FCF Yield % Historical Data

The historical data trend for Chromocell Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chromocell Therapeutics FCF Yield % Chart

Chromocell Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Chromocell Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial							-	-	-	-	-52.74

Competitive Comparison of Chromocell Therapeutics's FCF Yield %

For the Biotechnology subindustry, Chromocell Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chromocell Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chromocell Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Chromocell Therapeutics's FCF Yield % falls into.

Chromocell Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Chromocell Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.981	/	0
	=	N/A%

Chromocell Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.992	*	4	/	15.108754
	=	-52.74%

Chromocell Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Chromocell Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Chromocell Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.